Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Digital frontlines: leveraging AI to augment human expertise in crisis and combat situations
    Published on 2025-09-29
    8 months ago
  • Dorsomedial striatal neuroinflammation causes excessive goal-directed action control by disrupting astrocyte function
    Published on 2025-09-27
    8 months ago
  • In Memoriam: Terry A. Ketter, MD
    Published on 2025-09-26
    8 months ago
  • A review of the impact of structural racism on lived experiences of adolescents of African descent: Implications for development, brain structure, and health
    Published on 2025-09-26
    8 months ago
  • Building brain resilience through brain capital
    Published on 2025-09-26
    8 months ago
  • Role of molecularly defined lateral septum cell types and circuits in social behaviors
    Published on 2025-09-26
    8 months ago
  • There is still so much work to be done: a mother’s perspective
    Published on 2025-09-25
    8 months ago
« Previous 1 … 28 29 30 31 32 … 143 Next »
Journal of Psychopharmacology
  • The Afterglow Inventory (AGI): Validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics
    Published on 2025-04-01
    1 year ago
  • The anti-inflammation pharmacodynamics of lithium: Therapy of bipolar disorder
    Published on 2025-03-26
    1 year ago
  • Evaluating the efficacy of metformin in reducing hyperprolactinemia among patients with schizophrenia: A meta-analysis of randomized controlled trials
    Published on 2025-03-25
    1 year ago
  • Monoamine neurotransmitter-related gene-based genome-wide association study of low-dose ketamine in patients with treatment-resistant depression
    Published on 2025-03-25
    1 year ago
  • Exploring the impact of MDMA and oxytocin ligands on anxiety and social responses: A comprehensive behavioural and molecular study in the zebrafish model
    Published on 2025-03-25
    1 year ago
  • Effect of ashwagandha (Withania somnifera) extract with Sominone (Somin-On™) to improve memory in adults with mild cognitive impairment: A randomized, double-blind, placebo-controlled study
    Published on 2025-03-18
    1 year ago
  • A randomized, placebo-controlled, double-blind, pilot study of cannabis-related driving impairment assessed by driving simulator and self-report
    Published on 2025-03-13
    1 year ago
« Previous 1 … 28 29 30 31 32 … 146 Next »
European Neuropsychopharmacology
  • Letter to the editor concerning: “Efficacy, tolerability, and safety of xanomeline-trospium chloride for schizophrenia: A systematic review and meta-analysis”
    Published on 2025-02-16
    1 year ago
  • Methylation profile scores of environmental exposures and risk of relapse after a first episode of schizophrenia
    Published on 2025-02-16
    1 year ago
  • Artificial intelligence in healthcare: Revolution or unfulfilled promise?
    Published on 2025-02-16
    1 year ago
  • Prescription sequences in bipolar disorder – A nationwide Danish register-based study of 19,927 individuals followed for 10 years
    Published on 2025-02-16
    1 year ago
  • Whole-brain functional neuroimaging correlates of cognitive flexibility impairments in people with mental disorders: A transdiagnostic coordinate-based meta-analysis
    Published on 2025-02-16
    1 year ago
  • Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: Findings from a 32-week randomised, open-label, rater-blinded phase IIIb study
    Published on 2025-02-09
    1 year ago
  • Lack of antidepressant-like effect of imipramine, fluoxetine and ketamine in the forced swim test in mice: How much standardization does a positive control require?
    Published on 2025-02-05
    1 year ago
« Previous 1 … 28 29 30 31 32 … 166 Next »

   Pharma Pub